Floatz logo

Ast-201

Liver Neoplasms

Aptamer Sciences, Inc.vaccinePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

23 Active assets in the Liver Neoplasms cohort.

Asset / SponsorPhaseRating
Irinotecan
Tehran University of Medical Sciences
Phase 4BBB
Eloxatin
Shanghai Zhongshan Hospital
Phase 4BB
CHLORHEXIDINE
Changhua Christian Hospital
Phase 4BB
ALBUMIN AGGREGATED
Sirtex Medical
Phase 4BB
FLUOROURACILUM
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 4BB

View all 50 →

Same molecule, other indications

Ast-201 is also rated in:

ovarian cancerDormant
CCC
Indicative ·
53 / 100
View asset →
hepatocellular carcinomaDormant
CC
Indicative ·
41 / 100
View asset →
neoplasmDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →